Table 1. Baseline characteristics and change in parameters after 12 weeks.
| Characteristic | Baseline | Week 12 | P value |
|---|---|---|---|
| Group distribution, A:B:C:D | 5:5:16:3 | - | - |
| Age, yr | 53.9±9.1 | - | - |
| Sex, male:female | 20:9 | - | - |
| Lipid-lowering agents | 19 (65.5) | - | - |
| Antihypertensive agents | 10 (34.5) | - | - |
| Body weight, kg | 69.5±12.4 | 69.1±12.2 | 0.245 |
| Body mass index, kg/m2 | 25.0±2.8 | 24.9±2.8 | 0.309 |
| Fasting plasma glucose, mg/dL | 140.9±39.1 | 120.1±31.0 | 0.009 |
| HbA1c, % | 7.7±0.7 | 7.1±0.6 | <0.001 |
| Total cholesterol, mg/dL | 163.1±33.0 | 166.0±37.0 | 0.531 |
| Triglyceride, mg/dLa | 155.6±86.0 | 144.7±110.9 | 0.300 |
| LDL-C, mg/dL | 82.7±28.4 | 86.3±32.5 | 0.422 |
| HDL-C, mg/dL | 49.3±10.9 | 50.8±12.6 | 0.323 |
| AST, IU/La | 28.6±10.2 | 26.6±8.2 | 0.234 |
| ALT, IU/La | 34.1±23.8 | 27.3±11.3 | 0.089 |
Values are presented as mean±standard deviation or number (%).
HbA1c, glycosylated hemoglobin; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; AST, aspartate transaminase; ALT, alanine transaminase.
aParameters did not follow normal distribution.